| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.49 | 0.09 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |